Gynesonics
7
0
0
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
71.4%
5 terminated/withdrawn out of 7 trials
28.6%
-57.9% vs industry average
0%
0 trials in Phase 3/4
100%
2 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry
Role: lead
Sonography Guided Transcervical Ablation of Uterine Fibroids
Role: lead
Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of Fibroids
Role: lead
Fibroid Ablation Study
Role: lead
Fibroid Ablation Study - Large Fibroids
Role: lead
Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation
Role: lead
Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study
Role: lead
All 7 trials loaded